Ela Elyada

11.2k citations
19 papers · 8.6k · 6 hit papers · h-index 13

Impact in

  • Oncology top 0.5%
    • Cancer Cells and Metastasis
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Genomics and Diagnostics
    • Cancer, Hypoxia, and Metabolism

Papers in

    • Immune cells in cancer 5
    • Immunotherapy and Immune Responses 2
    • Cancer Cells and Metastasis 6
    • Pancreatic and Hepatic Oncology Research 5
    • Cancer-related Molecular Pathways 2

Ela Elyada

18 papers receiving 8.5k citations

Ela Elyada's Hit Papers

Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer 2021 · 236 citations
2360+4+8Years since publication50010001.5k2.0k

Peers

Ela Elyada
Comparison fields: 5 of 118
  • Oncology 5.2k
  • Cancer Research 1.8k
  • Immunology 2.1k
  • Molecular Biology 3.2k
  • Biotechnology 349
Replace Dannielle D. Engle with:
Dannielle D. Engle United States
Daniel Öhlund Sweden
Mara H. Sherman United States
Marina Pasca di Magliano United States
Sergey V. Novitskiy United States
Tobiloba E. Oni United States
Hao Yuan China
Michael A. Jacobetz United States
Chang‐Il Hwang United States
Matthew Ibbs Poland
Ela Elyada relative to Dannielle D. Engle United States Dannielle D. Engle's profile →
Citations per field
00.5×1.5×
Dannielle D. Engle · 1×
Citations per year

Countries citing papers authored by Ela Elyada

Since Specialization
Citations

This map shows the geographic impact of Ela Elyada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ela Elyada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ela Elyada more than expected).

Fields of papers citing papers by Ela Elyada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ela Elyada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ela Elyada. The network helps show where Ela Elyada may publish in the future.

Co-authors

The 25 scholars most cited alongside Ela Elyada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ela Elyada Line = papers co-authored together Ela Elyada links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
Hit paper breakdown →
20172006
2
Organoid Models of Human and Mouse Ductal Pancreatic Cancer
Hit paper breakdown →
20141753
3
Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts
Hit paper breakdown →
20191613
4
IL1-Induced JAK/STAT Signaling Is Antagonized by TGFβ to Shape CAF Heterogeneity in Pancreatic Ductal Adenocarcinoma
Hit paper breakdown →
20181081
5
Fibroblast heterogeneity in the cancer wound
Hit paper breakdown →
2014766
6 2020295
7 2020287
8
Inhibition of Hedgehog Signaling Alters Fibroblast Composition in Pancreatic Cancer
Hit paper breakdown →
2021236
9 2013204
10 2011168
11 202368
12 202460
13 201716
14 201613
15 20149
16 20153
17 20161
18 20141
19 20260

About Ela Elyada

Ela Elyada is a scholar working on Immunology, Oncology, Molecular Biology, Biological Psychiatry and Rehabilitation, having authored 19 papers that have together received 8.6k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (6 papers), Immune cells in cancer (5 papers), Pancreatic and Hepatic Oncology Research (5 papers), Epigenetics and DNA Methylation (2 papers), Cancer-related Molecular Pathways (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Immunotherapy and Immune Responses (2 papers) and Telomeres, Telomerase, and Senescence (2 papers). The work is most often cited by research in Oncology (5.2k citations), Cancer Research (1.8k citations), Immunology (2.1k citations), Molecular Biology (3.2k citations) and Biotechnology (349 citations). Ela Elyada has collaborated with scholars based in United States, Israel and Germany. Frequent co-authors include David Arthur Tuveson, Daniel Öhlund, Jonathan B. Preall, Hao Yuan, Tobiloba E. Oni, Benjamin P. Spielman, Youngkyu Park, Giulia Biffi, Yinon Ben‐Neriah and Moshe Oren. Their work appears in journals such as Nature, The Journal of Experimental Medicine, Cancer Cell, Cancer Discovery and Cytokine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact